[go: up one dir, main page]

UA80831C2 - Sustained-release table composition of pramipexole in a form of an orally deliverable tablet and method of patient treatment - Google Patents

Sustained-release table composition of pramipexole in a form of an orally deliverable tablet and method of patient treatment

Info

Publication number
UA80831C2
UA80831C2 UAA200500638A UA2005000638A UA80831C2 UA 80831 C2 UA80831 C2 UA 80831C2 UA A200500638 A UAA200500638 A UA A200500638A UA 2005000638 A UA2005000638 A UA 2005000638A UA 80831 C2 UA80831 C2 UA 80831C2
Authority
UA
Ukraine
Prior art keywords
pramipexole
sustained
orally deliverable
patient treatment
release table
Prior art date
Application number
UAA200500638A
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Priority claimed from PCT/US2003/023205 external-priority patent/WO2004010997A1/en
Publication of UA80831C2 publication Critical patent/UA80831C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

A sustained-release pharmaceutical composition in a form of an orally deliverable tablet comprises a water-soluble salt of pramipexole, dispersed in a matrix comprising a hydrophilic polymer and a starch having a tensile strength of at least about 0.15 kN cm-2 at a solid fraction representative of a tablet.
UAA200500638A 2003-06-18 2003-07-25 Sustained-release table composition of pramipexole in a form of an orally deliverable tablet and method of patient treatment UA80831C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47951303P 2003-06-18 2003-06-18
PCT/US2003/023205 WO2004010997A1 (en) 2002-07-25 2003-07-25 Sustained-release tablet composition of pramipexole

Publications (1)

Publication Number Publication Date
UA80831C2 true UA80831C2 (en) 2007-11-12

Family

ID=39016678

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200500638A UA80831C2 (en) 2003-06-18 2003-07-25 Sustained-release table composition of pramipexole in a form of an orally deliverable tablet and method of patient treatment

Country Status (1)

Country Link
UA (1) UA80831C2 (en)

Similar Documents

Publication Publication Date Title
RS20050059A (en) Sustained-release tablet compositions of pramipexole
MY136318A (en) Sustained-release tablet composition
MY130332A (en) Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
GB9410533D0 (en) In situ hybridisation and immuno-Chemical localisation of a growth factor
MX2008000099A (en) Modified release pharmaceutical compositions on the basis of two polymers and processes thereof.
WO2002041837A3 (en) Treatment of mucositis
EP1658849A3 (en) therapeutic combinations of antihypertensive and antiangiogenic agents
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
EP2813511A3 (en) Ferric organic compounds, uses thereof and methods of making same
MXPA03010402A (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives.
MX339071B (en) Pregelatinized starch in a controlled release formulation.
TNSN00252A1 (en) PHARMACEUTICAL COMPOSITIONS GENERATING INCREASED CONCENTRATIONS OF DRUGS
CY1107838T1 (en) ADAMANTANIUM PRODUCTION FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOGRAPHIC DISEASES
EP2172246A3 (en) Methods for Alzheimer's disease treatment and cognitive enhancement
CY1112184T1 (en) PYRIDOXAMINE FOR USE IN TREATMENT OF DIABETIC Nephropathy in Type II Diabetes
WO2004098564A3 (en) Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide
TW200637546A (en) Combination therapy
MY137516A (en) Pharmaceutical composition comprising lumiracoxib
WO2002056745A3 (en) Method of treating parkinson's disease
PL1680112T3 (en) N-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin or a pharmaceutically salt thereof for use in the treatment of insulin resistance
UA80831C2 (en) Sustained-release table composition of pramipexole in a form of an orally deliverable tablet and method of patient treatment
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
WO2004096155A3 (en) Tablets and methods for modified release of hydrophilic and other active agents
AU3478600A (en) Treatment of autoimmune diseases with american ginseng extract
HRP20040165B1 (en) Citalopram for the treatment of elevated blood pressure